chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 65.0
Sex: M
Vaccine: COVID19-2
Symptoms: Ageusia, Anosmia, Asthenia, Body temperature increased, Extra dose administered
Clinical narrative: I had classic COVID-19 symptoms intense headache a temperature of 101.6 I felt achy and weak I was loosing my sense of smell and taste. The symptoms came on twenty-four hours after the the shot and seemed to be resolved forty eight hours after the shot then returned sixty hours after the shot and was chronic for three days me spending three and one half days in bed and I still experience upper respiratory symptoms a productive cough with nasal congestion.
Age: 65.0
Sex: M
Vaccine: COVID19-2
Symptoms: Headache, Malaise, Mobility decreased, Nasal congestion, Pain
Clinical narrative: I had classic COVID-19 symptoms intense headache a temperature of 101.6 I felt achy and weak I was loosing my sense of smell and taste. The symptoms came on twenty-four hours after the the shot and seemed to be resolved forty eight hours after the shot then returned sixty hours after the shot and was chronic for three days me spending three and one half days in bed and I still experience upper respiratory symptoms a productive cough with nasal congestion.
Age: 65.0
Sex: M
Vaccine: COVID19-2
Symptoms: Productive cough, Respiratory symptom, SARS-CoV-2 test
Clinical narrative: I had classic COVID-19 symptoms intense headache a temperature of 101.6 I felt achy and weak I was loosing my sense of smell and taste. The symptoms came on twenty-four hours after the the shot and seemed to be resolved forty eight hours after the shot then returned sixty hours after the shot and was chronic for three days me spending three and one half days in bed and I still experience upper respiratory symptoms a productive cough with nasal congestion.
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: covid positive pt, vaccinated, hospitalized
Age: 91.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Cough, Dizziness, Nausea, Pyrexia
Clinical narrative: FEVER, DIZZINESS, SNEEZING, COUGHING AND NAUSEA
Age: 91.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: SARS-CoV-2 test positive, Sneezing
Clinical narrative: FEVER, DIZZINESS, SNEEZING, COUGHING AND NAUSEA
Age: 71.0
Sex: F
Vaccine: COVID19-2
Symptoms: Chest X-ray, Malaise, SARS-CoV-2 test negative
Clinical narrative: I had all the symptoms of Covid except no fever. Lasting so far for one week.
Age: 5.0
Sex: F
Vaccine: COVID19
Symptoms: Product preparation error
Clinical narrative: Vial was not diluted, stronger dose given. Mom notified at 9am to monitor. Mom stated child was playing and injection site OK.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19 pneumonia, Death, Heart rate increased, Hypoxia, Pneumonia aspiration
Clinical narrative: MODERNA COVID VACCINE #3 GIVEN 11/2/21, LOT #045C21A; patient had a previous hospitalization for COVID pneumonia and respiratory failure (dates and tx not in medical records); patient had a second hospitalization from 2/4/22 - 2/14/22 for worsening hypoxia and increasing heart rate, complicated by aspiration pneumonia; patient finished steroids and ABX in hospital; required supplemental O2; DNR/Comfort Care; DC'd to hospice care where he passed away.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Respiratory failure
Clinical narrative: MODERNA COVID VACCINE #3 GIVEN 11/2/21, LOT #045C21A; patient had a previous hospitalization for COVID pneumonia and respiratory failure (dates and tx not in medical records); patient had a second hospitalization from 2/4/22 - 2/14/22 for worsening hypoxia and increasing heart rate, complicated by aspiration pneumonia; patient finished steroids and ABX in hospital; required supplemental O2; DNR/Comfort Care; DC'd to hospice care where he passed away.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Headache, Impaired work ability, Loss of personal independence in daily activities
Clinical narrative: I had headaches ever day. They didn?t go away with Motrin. After I realized I had headaches every day for a month I called my Dr. They said go to the ER. The IV treatment at the ER gave me relief for one day then the headaches came back. My Dr tried Prozac in case it was stress and anxiety, but after two weeks I had an allergic reaction and the headaches weren?t helped. Then I went to a neurologist. I had daily migraine non-stop for 4 months before I started finding relief. My life has been completely changed. The pain was so terrible. Now I am on a lot of daily medicine and a monthly shot which looks promising but I haven?t been in it long enough yet.  I lose a day of work occasionally.  My triggers are many and instant. This is nothing like the two migraines and some headaches a year I used to have that didn?t affect my daily life so much.
Age: 2.0
Sex: M
Vaccine: COVID19
Symptoms: Product preparation error
Clinical narrative: vial was not diluted stronger dose was given mom notified at 9am, advised to monitor mom stated injection site was ok
Age: 32.0
Sex: M
Vaccine: FLUR4
Symptoms: Orbital swelling
Clinical narrative: Swelling of left orbit
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Dizziness, SARS-CoV-2 test positive
Clinical narrative: LIGHTHEADED AND DIZZY,,
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: covid vaccine breakthrough  dose 1 2/9/21 Pfizer EL9269 dose 2 3/2/21 Pfizer EN6198 dose 2 unknown lot number
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Body temperature increased, COVID-19 pneumonia, Computerised tomogram thorax abnormal, Dyspnoea, Hypoxia
Clinical narrative: 1/27/2022- Presented to ER, complaint of SOB. Temp-101.5. p-90. Chest CT-Coarse interstitial disease with ground-glass opacities. Admit Sepsis/Acute hypoxia secondary to Covid 19 pneumonia. IV decadron, IV Remdesivir, baricitinib, vitamins, ceftriaxone and doxycycline. 1/29/2022-Spo2 stable on RA. Afebrile. 1/30/2022-VSS, discharged to home.
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Interstitial lung disease, Lung opacity, Sepsis
Clinical narrative: 1/27/2022- Presented to ER, complaint of SOB. Temp-101.5. p-90. Chest CT-Coarse interstitial disease with ground-glass opacities. Admit Sepsis/Acute hypoxia secondary to Covid 19 pneumonia. IV decadron, IV Remdesivir, baricitinib, vitamins, ceftriaxone and doxycycline. 1/29/2022-Spo2 stable on RA. Afebrile. 1/30/2022-VSS, discharged to home.
Age: 67.0
Sex: F
Vaccine: COVID19-2
Symptoms: Rash
Clinical narrative: rash development on side, arms, scalp
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: covid vaccine breakthrough case  dose 1 1/24/21 Pfizer EL9261 dose 2 2/14/21 Pfizer EM9810
Age: 12.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: BUD 9/2/2022 PATIENT RECEIVED VACCINE ON 9/12/2022
Age: 35.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vomiting
Clinical narrative: VOMITING.
Age: 74.0
Sex: F
Vaccine: COVID19-2
Symptoms: Asthenia, Back pain, Blood test, Computerised tomogram, Haemoglobin decreased
Clinical narrative: Flu=like symptoms, body ache, nausea, weakness all over body, no fever back pain led to hospitalization. Blood work, CT scan, and rectal exam, Blood hemoglobin at 6.5. Blood transfusion procedures completed
Age: 74.0
Sex: F
Vaccine: COVID19-2
Symptoms: Influenza like illness, Nausea, Pain, Rectal examination, Transfusion
Clinical narrative: Flu=like symptoms, body ache, nausea, weakness all over body, no fever back pain led to hospitalization. Blood work, CT scan, and rectal exam, Blood hemoglobin at 6.5. Blood transfusion procedures completed
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: covid vaccine breakthrough case  dose 1 1/5/21 EL0140 dose 2 1/26/21 EL3249
Age: 52.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Patient did not inform clinic that he had received his first dose at Health Department on 8/13/2022.  He therefore received his second dose 14 days too earlier.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: covid vaccine breakthrough case  dose 1 Pfizer 2/5/21 EL 3248 dose 2 Pfizer 2/26/21 EN 6200
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Hypertension, SARS-CoV-2 test positive, Small intestinal obstruction
Clinical narrative: The patient presented to emergency dept on 9/10/22 with cough, small bowel obstruction, and high blood pressure. He tested positive for COVID on 9/10/22. He was stabilized and discharged on 9/12/22.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Chills, Cough, Dyspnoea, Pyrexia
Clinical narrative: chills, fever, congestion, cough, SOB, chest pain
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Respiratory tract congestion
Clinical narrative: chills, fever, congestion, cough, SOB, chest pain
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: covid vaccine breakthrough case
Age: 34.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Headache, Heart rate increased, Malaise, Muscle tightness, Nausea
Clinical narrative: Since receiving the vaccine I have generally felt unwell with periodic headaches, nausea, and muscle tension. Today my smart watch notified me that my resting heart rate has been elevated for the last week (60 bpm average  in the preceding 3 weeks vs. 68 bpm in the week since vaccine).
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: covid vaccine breakthrough case
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Confusional state, Fatigue
Clinical narrative: fatigue, weakness, confusion
Age: 79.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: COVID-19, Dyspnoea, Hypoxia, SARS-CoV-2 test positive
Clinical narrative: SOB, HYPOXIA,
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Dyspnoea, Headache
Clinical narrative: cough, SOB, headaches
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Patient vaccinated against then tested positive for COVID-19
Age: 20.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Patient vaccinated against then tested positive for COVID-19
Age: 51.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: COVID-19, Chest pain, Dyspnoea, SARS-CoV-2 test positive
Clinical narrative: CHEST PAIN AND BREATHING PROBLEMS
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: covid vaccine breakthrough event  dose 1 2/2/21 013M20A dose 2 3/2/21 010A21A dose 3 11/19/21 034F21A
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cough, Respiratory tract congestion
Clinical narrative: Chills, congestion, and cough.
Age: 0.5
Sex: M
Vaccine: DTAPIPVHIB, HEP, PNC13, RV5
Symptoms: Pyrexia, Urticaria
Clinical narrative: Whelts, fever 20 hours after receiving the vaccines.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Dizziness, Nausea, Vaginal haemorrhage
Clinical narrative: abdominal pain, nausea, vaginal bleeding, light-headedness
Age: 27.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Patient vaccinated against, then tested positive for COVID-19
Age: 13.0
Sex: F
Vaccine: DTAPIPV
Symptoms: Wrong product administered
Clinical narrative: no adverse events, patient inadvertently received Quadracel. I followed up, no harm to patient, mother made aware. Patient was here for Tdap requirement. He and his brother were in the same room and brother was receiving Quadrcel with his vaccines.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Dyspnoea
Clinical narrative: SOB, chest pain.
Age: 18.0
Sex: F
Vaccine: MENB
Symptoms: Dizziness, Head injury, Migraine, Nausea, Pain in extremity
Clinical narrative: LOW FEVER, R ARM PAIN, VOMITING, DIZZY, NAUSEA, SEVERE MIGRAINES - LASTED 3 DAYS  DIZZY AFTER VOMITING, HIT HEAD ON CABINET AND HAD TO GO TO ER FOR STITCH TO FOREHEAD LAC
Age: 18.0
Sex: F
Vaccine: MENB
Symptoms: Pyrexia, Suture insertion, Vomiting
Clinical narrative: LOW FEVER, R ARM PAIN, VOMITING, DIZZY, NAUSEA, SEVERE MIGRAINES - LASTED 3 DAYS  DIZZY AFTER VOMITING, HIT HEAD ON CABINET AND HAD TO GO TO ER FOR STITCH TO FOREHEAD LAC
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Dyspnoea, Fatigue
Clinical narrative: fatigue, SOB, light-headedness
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Dyspnoea, Hypoxia, SARS-CoV-2 test positive, Wheezing
Clinical narrative: SOB, WHEEZING, HYPOXIA
Age: 4.0
Sex: M
Vaccine: DTAPIPVHIB, MMRV, PNC13
Symptoms: Product storage error
Clinical narrative: Pt was given a vaccine(MMRV) that had a temperature excursion.
Age: 55.0
Sex: F
Vaccine: COVID19-2
Symptoms: Anxiety, Dizziness, Nausea, Nervousness
Clinical narrative: Nausea, Lightheaded, Nervous/Anxious Feeling.
Age: 50.0
Sex: M
Vaccine: UNK
Symptoms: Blister rupture, Injection site vesicles
Clinical narrative: Blister at injection site started following day. Fluid filled, opens after showering. Followed up with PCP. Prescribed antibiotics. Blister continues to reform daily.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, COVID-19, Chills, Decreased appetite, SARS-CoV-2 test positive
Clinical narrative: WEAKNESS, CHILLS, DECREASED APPETITE.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Fatigue, Headache, Oropharyngeal pain, Pyrexia
Clinical narrative: fatigue, fever, sore throat, cough, headaches
Age: 65.0
Sex: M
Vaccine: COVID19, FLUA4
Symptoms: Angiopathy, Brain natriuretic peptide normal, COVID-19, Chest X-ray abnormal, Chills
Clinical narrative: Admission Date: 9/13/2022 Discharge Date: 9/16/2022  PRESENTING PROBLEM: COPD with acute exacerbation COVID-19   HOSPITAL COURSE:    The patent is a 66 y.o. male with past medical history of asthma, chronic obstructive pulmonary disease, home O2 6 liters/minute nasal cannula oxygen supplement, obstructive sleep apnea on BiPAP at home, chronic systolic and diastolic congestive heart failure, coronary artery disease, hypertension, and diabetes mellitus type 2.   He presents to the hospital on 9/13/2022 with difficulty breathing, diaphoresis, chills, coughing with some phlegm, increased dyspnea with exertion. On 9/13/2022, his primary care physician appointment diagnosed with COVID-19 infection.     Chest x-ray showed mild vascular congestion but normal BNP.  His troponin -18 and he has leukocytosis 13,000.  Recently the patient was on prednisone 20 mg orally daily for his asthma, but so far that was tapered down to 5 mg of prednisone daily only. Received 3 days of remdesivir. Patient was started on decadron, doxycycline for a five day course, will be discharge with 3 days to complete the course. Once the decadron course is completed patient will resume prednisone 5 mg daily as prescribed by pulmonary doctor.  Lasix 40 mg IV BID started, but was switch to home dose lasix 40 mg PO BID yesterday. Net IO Since Admission: -4,898 mL [09/16/22 1024] Weight on admission 103.8kg, 100.3 kg at discharge. Recommend echocardiogram outpatient. Patient discharged with 40 mg lasix once daily- patient reports taking daily weights at home. Discuss a heart healthy diet, sodium restriction, and limiting fluids. He will need follow up with PCP to evaluate diuretic requirements.    Patient was seen and examined. He is alert and oriented. Patient is asking to go home and feels that he is at baseline. Reports shortness of breath is at baseline. Denies chest pain, headache, n/v/d/c, abdominal pain. Patient is discharged in stable condition- all labs and imaging reviewed. No concerns at this time. All questions were answered prior to discharge.
Age: 65.0
Sex: M
Vaccine: COVID19, FLUA4
Symptoms: Chronic obstructive pulmonary disease, Condition aggravated, Dyspnoea, Dyspnoea exertional, Hyperhidrosis
Clinical narrative: Admission Date: 9/13/2022 Discharge Date: 9/16/2022  PRESENTING PROBLEM: COPD with acute exacerbation COVID-19   HOSPITAL COURSE:    The patent is a 66 y.o. male with past medical history of asthma, chronic obstructive pulmonary disease, home O2 6 liters/minute nasal cannula oxygen supplement, obstructive sleep apnea on BiPAP at home, chronic systolic and diastolic congestive heart failure, coronary artery disease, hypertension, and diabetes mellitus type 2.   He presents to the hospital on 9/13/2022 with difficulty breathing, diaphoresis, chills, coughing with some phlegm, increased dyspnea with exertion. On 9/13/2022, his primary care physician appointment diagnosed with COVID-19 infection.     Chest x-ray showed mild vascular congestion but normal BNP.  His troponin -18 and he has leukocytosis 13,000.  Recently the patient was on prednisone 20 mg orally daily for his asthma, but so far that was tapered down to 5 mg of prednisone daily only. Received 3 days of remdesivir. Patient was started on decadron, doxycycline for a five day course, will be discharge with 3 days to complete the course. Once the decadron course is completed patient will resume prednisone 5 mg daily as prescribed by pulmonary doctor.  Lasix 40 mg IV BID started, but was switch to home dose lasix 40 mg PO BID yesterday. Net IO Since Admission: -4,898 mL [09/16/22 1024] Weight on admission 103.8kg, 100.3 kg at discharge. Recommend echocardiogram outpatient. Patient discharged with 40 mg lasix once daily- patient reports taking daily weights at home. Discuss a heart healthy diet, sodium restriction, and limiting fluids. He will need follow up with PCP to evaluate diuretic requirements.    Patient was seen and examined. He is alert and oriented. Patient is asking to go home and feels that he is at baseline. Reports shortness of breath is at baseline. Denies chest pain, headache, n/v/d/c, abdominal pain. Patient is discharged in stable condition- all labs and imaging reviewed. No concerns at this time. All questions were answered prior to discharge.
Age: 65.0
Sex: M
Vaccine: COVID19, FLUA4
Symptoms: Imaging procedure, Laboratory test normal, Leukocytosis, Productive cough, Troponin
Clinical narrative: Admission Date: 9/13/2022 Discharge Date: 9/16/2022  PRESENTING PROBLEM: COPD with acute exacerbation COVID-19   HOSPITAL COURSE:    The patent is a 66 y.o. male with past medical history of asthma, chronic obstructive pulmonary disease, home O2 6 liters/minute nasal cannula oxygen supplement, obstructive sleep apnea on BiPAP at home, chronic systolic and diastolic congestive heart failure, coronary artery disease, hypertension, and diabetes mellitus type 2.   He presents to the hospital on 9/13/2022 with difficulty breathing, diaphoresis, chills, coughing with some phlegm, increased dyspnea with exertion. On 9/13/2022, his primary care physician appointment diagnosed with COVID-19 infection.     Chest x-ray showed mild vascular congestion but normal BNP.  His troponin -18 and he has leukocytosis 13,000.  Recently the patient was on prednisone 20 mg orally daily for his asthma, but so far that was tapered down to 5 mg of prednisone daily only. Received 3 days of remdesivir. Patient was started on decadron, doxycycline for a five day course, will be discharge with 3 days to complete the course. Once the decadron course is completed patient will resume prednisone 5 mg daily as prescribed by pulmonary doctor.  Lasix 40 mg IV BID started, but was switch to home dose lasix 40 mg PO BID yesterday. Net IO Since Admission: -4,898 mL [09/16/22 1024] Weight on admission 103.8kg, 100.3 kg at discharge. Recommend echocardiogram outpatient. Patient discharged with 40 mg lasix once daily- patient reports taking daily weights at home. Discuss a heart healthy diet, sodium restriction, and limiting fluids. He will need follow up with PCP to evaluate diuretic requirements.    Patient was seen and examined. He is alert and oriented. Patient is asking to go home and feels that he is at baseline. Reports shortness of breath is at baseline. Denies chest pain, headache, n/v/d/c, abdominal pain. Patient is discharged in stable condition- all labs and imaging reviewed. No concerns at this time. All questions were answered prior to discharge.
Age: 65.0
Sex: M
Vaccine: COVID19, FLUA4
Symptoms: White blood cell count increased
Clinical narrative: Admission Date: 9/13/2022 Discharge Date: 9/16/2022  PRESENTING PROBLEM: COPD with acute exacerbation COVID-19   HOSPITAL COURSE:    The patent is a 66 y.o. male with past medical history of asthma, chronic obstructive pulmonary disease, home O2 6 liters/minute nasal cannula oxygen supplement, obstructive sleep apnea on BiPAP at home, chronic systolic and diastolic congestive heart failure, coronary artery disease, hypertension, and diabetes mellitus type 2.   He presents to the hospital on 9/13/2022 with difficulty breathing, diaphoresis, chills, coughing with some phlegm, increased dyspnea with exertion. On 9/13/2022, his primary care physician appointment diagnosed with COVID-19 infection.     Chest x-ray showed mild vascular congestion but normal BNP.  His troponin -18 and he has leukocytosis 13,000.  Recently the patient was on prednisone 20 mg orally daily for his asthma, but so far that was tapered down to 5 mg of prednisone daily only. Received 3 days of remdesivir. Patient was started on decadron, doxycycline for a five day course, will be discharge with 3 days to complete the course. Once the decadron course is completed patient will resume prednisone 5 mg daily as prescribed by pulmonary doctor.  Lasix 40 mg IV BID started, but was switch to home dose lasix 40 mg PO BID yesterday. Net IO Since Admission: -4,898 mL [09/16/22 1024] Weight on admission 103.8kg, 100.3 kg at discharge. Recommend echocardiogram outpatient. Patient discharged with 40 mg lasix once daily- patient reports taking daily weights at home. Discuss a heart healthy diet, sodium restriction, and limiting fluids. He will need follow up with PCP to evaluate diuretic requirements.    Patient was seen and examined. He is alert and oriented. Patient is asking to go home and feels that he is at baseline. Reports shortness of breath is at baseline. Denies chest pain, headache, n/v/d/c, abdominal pain. Patient is discharged in stable condition- all labs and imaging reviewed. No concerns at this time. All questions were answered prior to discharge.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Exposure to SARS-CoV-2, Extra dose administered, Fatigue, Injection site pain
Clinical narrative: I had a little pain in my arm  at the injection site.  I tested positive with a home test for COVID-19 on 09/14/2022.  We had attended a couple of family events at which time I believe I got exposed to the virus. I had head congestion, sore throat for half a day and tired.  I contacted my doctor on 09/14/2022 for the prescription for Paxlovid.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Nasal congestion, Oropharyngeal pain, SARS-CoV-2 test positive
Clinical narrative: I had a little pain in my arm  at the injection site.  I tested positive with a home test for COVID-19 on 09/14/2022.  We had attended a couple of family events at which time I believe I got exposed to the virus. I had head congestion, sore throat for half a day and tired.  I contacted my doctor on 09/14/2022 for the prescription for Paxlovid.
Age: 72.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Erythema, Papule, Peripheral swelling, Pruritus, Rash
Clinical narrative: 7 days after vaccines delayed onset rash with a few itchy raised red papular lesions on arms.
Age: 72.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Skin lesion
Clinical narrative: 7 days after vaccines delayed onset rash with a few itchy raised red papular lesions on arms.
Age: 91.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Myalgia, Peripheral swelling
Clinical narrative: SOB, leg swelling, myalgias.
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: COVID-19, Cough, Dyspnoea, SARS-CoV-2 test positive
Clinical narrative: SOB AND COUGH
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Tremor
Clinical narrative: light-headedness, tremors
Age: 34.0
Sex: F
Vaccine: SMALLMNK
Symptoms: Vaccination error
Clinical narrative: Pt came in for second dose of the monkeypox, attempted to give in the left lower forearm but no wheel appeared. Pt was then revaccinated in the right lower forearm where a wheel appeared
Age: 1.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: RASH.
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Dyspnoea, Myalgia
Clinical narrative: cough, SOB, myalgias
Age: 36.0
Sex: F
Vaccine: COVID19-2, FLUX
Symptoms: COVID-19, Cough, Fatigue, Respiratory tract congestion, Rhinorrhoea
Clinical narrative: Congestion, lots of nasal fluid and cough, fatigue have been pretty mild. The doctor did a rapid and PCR test were given yesterday 9/19/22. She prescribed me FLONASE and MUCINEX but I'm not feeling that bad so haven't taken anything.
Age: 36.0
Sex: F
Vaccine: COVID19-2, FLUX
Symptoms: SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: Congestion, lots of nasal fluid and cough, fatigue have been pretty mild. The doctor did a rapid and PCR test were given yesterday 9/19/22. She prescribed me FLONASE and MUCINEX but I'm not feeling that bad so haven't taken anything.
Age: 88.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Abdominal distension, Acute respiratory failure, COVID-19, SARS-CoV-2 test positive
Clinical narrative: Patient was recently hospitalized for acute respiratory failure, diagnosed with COVID, was noted ot have abdominal distention
Age: 60.0
Sex: F
Vaccine: COVID19-2
Symptoms: Arthralgia, Body temperature increased
Clinical narrative: Temperature was elevated (99.2) and patient states every joint in her body hurts.
Age: 1.17
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: RASH
Age: 3.0
Sex: M
Vaccine: HEPA, TDAP
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Tdap given to patient outside the recommended age range
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Headache, Pyrexia, Respiratory tract congestion
Clinical narrative: fever, congestion, cough, headaches
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Immediate post-injection reaction, Injection site bruising, Injection site erythema, Injection site haemorrhage, Injection site pain
Clinical narrative: Adverse Event: Redness (circle of around 2.5 inches in diameter), pain, swelling at injection site, abnormal amount of bleeding from injection site immediately after administration (not normal for this writer), bruising and itching at injection site.  Treatment: None  Outcome: Redness is dissipating as of 9/20/22, site is still painful, bruising is still present.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pruritus, Injection site swelling
Clinical narrative: Adverse Event: Redness (circle of around 2.5 inches in diameter), pain, swelling at injection site, abnormal amount of bleeding from injection site immediately after administration (not normal for this writer), bruising and itching at injection site.  Treatment: None  Outcome: Redness is dissipating as of 9/20/22, site is still painful, bruising is still present.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Cough, Respiratory tract congestion
Clinical narrative: chest pain, cough, congestion
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Blood creatinine increased, COVID-19, Cough, Dyspnoea
Clinical narrative: Discharge Provider: MD Primary Care Provider at Discharge: MD  Admission Date: 9/12/2022 Discharge Date: 9/17/2022  PRESENTING PROBLEM: Acute hypoxemic respiratory failure (HCC)  Pneumonia due to COVID-19 virus COVID-19    HOSPITAL COURSE:  Patient is a very pleasant 71-year-old gentleman the past medical history reviewed and noted significant for moderate persistent asthma, essential hypertension and anxiety presented with shortness of breath and was found to have COVID-19 and bronchopneumonia.  Patient was also noted to have an elevated renal function with a creatinine of 1.41 and met sepsis criteria.  Patient did receive dexamethasone however after the 3rd dose of remdesivir a patient developed fluid overload and was diuresed with Lasix.  Patient continued to do well and was eventually weaned off oxygen.  His creatinine returned to normal.  His only symptom upon discharge was a residual cough.  He completed a 5 day course of ceftriaxone and azithromycin.  He was discharged with an additional 5 days of dexamethasone to complete a 10 day course.  He was encouraged to have a pulse oximeter and a blood pressure cuff to monitor his heart rate oxygen saturation and blood pressure along with primary nurse on when to return to ER.  Patient was agreeable with this plan.  Questions and concerns addressed.  Patient was discharged with the noted additional discharge instructions.  Patient was discharged in good condition to home with wife.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Hypervolaemia, Pneumonia, Renal impairment, Sepsis
Clinical narrative: Discharge Provider: MD Primary Care Provider at Discharge: MD  Admission Date: 9/12/2022 Discharge Date: 9/17/2022  PRESENTING PROBLEM: Acute hypoxemic respiratory failure (HCC)  Pneumonia due to COVID-19 virus COVID-19    HOSPITAL COURSE:  Patient is a very pleasant 71-year-old gentleman the past medical history reviewed and noted significant for moderate persistent asthma, essential hypertension and anxiety presented with shortness of breath and was found to have COVID-19 and bronchopneumonia.  Patient was also noted to have an elevated renal function with a creatinine of 1.41 and met sepsis criteria.  Patient did receive dexamethasone however after the 3rd dose of remdesivir a patient developed fluid overload and was diuresed with Lasix.  Patient continued to do well and was eventually weaned off oxygen.  His creatinine returned to normal.  His only symptom upon discharge was a residual cough.  He completed a 5 day course of ceftriaxone and azithromycin.  He was discharged with an additional 5 days of dexamethasone to complete a 10 day course.  He was encouraged to have a pulse oximeter and a blood pressure cuff to monitor his heart rate oxygen saturation and blood pressure along with primary nurse on when to return to ER.  Patient was agreeable with this plan.  Questions and concerns addressed.  Patient was discharged with the noted additional discharge instructions.  Patient was discharged in good condition to home with wife.
Age: 21.0
Sex: F
Vaccine: FLU4
Symptoms: Diarrhoea, Dizziness, Hyperhidrosis, Malaise, Nausea
Clinical narrative: 12-15 hours after vaccine administration (the following morning) symptoms of nausea, pale, diarrhea, faint, sweating, lightheadedness, dizziness. Near fainting, laid down with feet up to avoid. Feeling of nausea and malaise with possible fainting for 3-4 hours following original episode.
Age: 21.0
Sex: F
Vaccine: FLU4
Symptoms: Pallor, Presyncope, Syncope
Clinical narrative: 12-15 hours after vaccine administration (the following morning) symptoms of nausea, pale, diarrhea, faint, sweating, lightheadedness, dizziness. Near fainting, laid down with feet up to avoid. Feeling of nausea and malaise with possible fainting for 3-4 hours following original episode.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Dizziness, Fatigue, Nausea, Oropharyngeal pain
Clinical narrative: fatigue, fever, sore throat, abdominal pain, nausea, vomiting, dizziness
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vomiting
Clinical narrative: fatigue, fever, sore throat, abdominal pain, nausea, vomiting, dizziness
Age: 25.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Extra dose administered, Urticaria
Clinical narrative: Hives started forming all over body on 9/17/2022 and lasted until 9/20/2022. This was my 4th Covid vaccine - I received 3 Moderna vaccines previously (1/22/2021; 2/19/2021; 11/18/2021)
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Atelectasis, Bacterial test negative, Blood creatine phosphokinase increased
Clinical narrative: Discharge Provider: DO Primary Care Provider at Discharge: MD  Admission Date: 9/12/2022 Discharge Date: 9/15/2022  PRESENTING PROBLEM: Rhabdomyolysis [M62.82] Weakness [R53.1] Elevated CPK [R74.8] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 80 year old male who presented to the emergency department following a fall and weakness on 9/12/22. The previous night he had fallen while trying to get out of the bed and was lying on the floor until he was able to have neighbors help him back into bed. The morning of the 12th he still felt weak and couldn't get out of bed so he called 911 to bring him to the emergency department. Patient tested positive for COVID upon arrival. His SPO2 dropped down to 89 and patient was placed on 2L nasal cannula. Patient's labs indicated a CK of 3,033, BUN 21, Glucose 111 and urinalysis showed large amount of blood but no bacteria. Chest x-ray showed mild bibasilar lung atelectasis. X-ray of left hip and pelvis showed no fracture from fall. Due to history and elevated CK levels, rhabdomyolysis was suspected. Patient given IV 0.9% normal saline in the emergency department and was admitted to the hospital.   During his admittance, patient was started on DVT prophylaxis of Lovenox and SCDs along with an Albuterol inhaler PRN. He experienced off and on shortness and breath during his stay and alternated between 2L NC and room air due to dropping SPO2. On 9/13/22 Decadron 6mg PO daily and a one time dose of Remdesivir 200 mg IV followed by 2 doses of Remdesivir at 100 mg daily was ordered due to patient's shortness of breath and COVID. He has maintained his SPO2 on room air since 9/14/22. PT/OT evaluation and treatment was set up due to patient's new generalized weakness and hip pain from his fall. Patient also continued recieving 0.9% normal saline IV fluids throughout his stay. Continually checked CK levels, which have decreased from 3,033 to 1,655 down to 917 upon day of discharge.    Patient will be discharged to Facility on 9/15/22. The patient agrees with this plan of care and all questions and concerns were addressed to his satisfaction.  The patient had no significant complaints at the time of discharge and he was discharged in stable condition.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Blood glucose normal, Blood urea increased, Blood urine present, COVID-19, Chest X-ray abnormal
Clinical narrative: Discharge Provider: DO Primary Care Provider at Discharge: MD  Admission Date: 9/12/2022 Discharge Date: 9/15/2022  PRESENTING PROBLEM: Rhabdomyolysis [M62.82] Weakness [R53.1] Elevated CPK [R74.8] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 80 year old male who presented to the emergency department following a fall and weakness on 9/12/22. The previous night he had fallen while trying to get out of the bed and was lying on the floor until he was able to have neighbors help him back into bed. The morning of the 12th he still felt weak and couldn't get out of bed so he called 911 to bring him to the emergency department. Patient tested positive for COVID upon arrival. His SPO2 dropped down to 89 and patient was placed on 2L nasal cannula. Patient's labs indicated a CK of 3,033, BUN 21, Glucose 111 and urinalysis showed large amount of blood but no bacteria. Chest x-ray showed mild bibasilar lung atelectasis. X-ray of left hip and pelvis showed no fracture from fall. Due to history and elevated CK levels, rhabdomyolysis was suspected. Patient given IV 0.9% normal saline in the emergency department and was admitted to the hospital.   During his admittance, patient was started on DVT prophylaxis of Lovenox and SCDs along with an Albuterol inhaler PRN. He experienced off and on shortness and breath during his stay and alternated between 2L NC and room air due to dropping SPO2. On 9/13/22 Decadron 6mg PO daily and a one time dose of Remdesivir 200 mg IV followed by 2 doses of Remdesivir at 100 mg daily was ordered due to patient's shortness of breath and COVID. He has maintained his SPO2 on room air since 9/14/22. PT/OT evaluation and treatment was set up due to patient's new generalized weakness and hip pain from his fall. Patient also continued recieving 0.9% normal saline IV fluids throughout his stay. Continually checked CK levels, which have decreased from 3,033 to 1,655 down to 917 upon day of discharge.    Patient will be discharged to Facility on 9/15/22. The patient agrees with this plan of care and all questions and concerns were addressed to his satisfaction.  The patient had no significant complaints at the time of discharge and he was discharged in stable condition.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Dyspnoea, Fall, Mobility decreased, Oxygen saturation decreased
Clinical narrative: Discharge Provider: DO Primary Care Provider at Discharge: MD  Admission Date: 9/12/2022 Discharge Date: 9/15/2022  PRESENTING PROBLEM: Rhabdomyolysis [M62.82] Weakness [R53.1] Elevated CPK [R74.8] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 80 year old male who presented to the emergency department following a fall and weakness on 9/12/22. The previous night he had fallen while trying to get out of the bed and was lying on the floor until he was able to have neighbors help him back into bed. The morning of the 12th he still felt weak and couldn't get out of bed so he called 911 to bring him to the emergency department. Patient tested positive for COVID upon arrival. His SPO2 dropped down to 89 and patient was placed on 2L nasal cannula. Patient's labs indicated a CK of 3,033, BUN 21, Glucose 111 and urinalysis showed large amount of blood but no bacteria. Chest x-ray showed mild bibasilar lung atelectasis. X-ray of left hip and pelvis showed no fracture from fall. Due to history and elevated CK levels, rhabdomyolysis was suspected. Patient given IV 0.9% normal saline in the emergency department and was admitted to the hospital.   During his admittance, patient was started on DVT prophylaxis of Lovenox and SCDs along with an Albuterol inhaler PRN. He experienced off and on shortness and breath during his stay and alternated between 2L NC and room air due to dropping SPO2. On 9/13/22 Decadron 6mg PO daily and a one time dose of Remdesivir 200 mg IV followed by 2 doses of Remdesivir at 100 mg daily was ordered due to patient's shortness of breath and COVID. He has maintained his SPO2 on room air since 9/14/22. PT/OT evaluation and treatment was set up due to patient's new generalized weakness and hip pain from his fall. Patient also continued recieving 0.9% normal saline IV fluids throughout his stay. Continually checked CK levels, which have decreased from 3,033 to 1,655 down to 917 upon day of discharge.    Patient will be discharged to Facility on 9/15/22. The patient agrees with this plan of care and all questions and concerns were addressed to his satisfaction.  The patient had no significant complaints at the time of discharge and he was discharged in stable condition.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Rhabdomyolysis, SARS-CoV-2 test positive, Urine analysis abnormal, X-ray of pelvis and hip normal
Clinical narrative: Discharge Provider: DO Primary Care Provider at Discharge: MD  Admission Date: 9/12/2022 Discharge Date: 9/15/2022  PRESENTING PROBLEM: Rhabdomyolysis [M62.82] Weakness [R53.1] Elevated CPK [R74.8] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 80 year old male who presented to the emergency department following a fall and weakness on 9/12/22. The previous night he had fallen while trying to get out of the bed and was lying on the floor until he was able to have neighbors help him back into bed. The morning of the 12th he still felt weak and couldn't get out of bed so he called 911 to bring him to the emergency department. Patient tested positive for COVID upon arrival. His SPO2 dropped down to 89 and patient was placed on 2L nasal cannula. Patient's labs indicated a CK of 3,033, BUN 21, Glucose 111 and urinalysis showed large amount of blood but no bacteria. Chest x-ray showed mild bibasilar lung atelectasis. X-ray of left hip and pelvis showed no fracture from fall. Due to history and elevated CK levels, rhabdomyolysis was suspected. Patient given IV 0.9% normal saline in the emergency department and was admitted to the hospital.   During his admittance, patient was started on DVT prophylaxis of Lovenox and SCDs along with an Albuterol inhaler PRN. He experienced off and on shortness and breath during his stay and alternated between 2L NC and room air due to dropping SPO2. On 9/13/22 Decadron 6mg PO daily and a one time dose of Remdesivir 200 mg IV followed by 2 doses of Remdesivir at 100 mg daily was ordered due to patient's shortness of breath and COVID. He has maintained his SPO2 on room air since 9/14/22. PT/OT evaluation and treatment was set up due to patient's new generalized weakness and hip pain from his fall. Patient also continued recieving 0.9% normal saline IV fluids throughout his stay. Continually checked CK levels, which have decreased from 3,033 to 1,655 down to 917 upon day of discharge.    Patient will be discharged to Facility on 9/15/22. The patient agrees with this plan of care and all questions and concerns were addressed to his satisfaction.  The patient had no significant complaints at the time of discharge and he was discharged in stable condition.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Fatigue
Clinical narrative: cough, fatigue
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: No adverse reaction- incorrect vaccine given dose should have Been Covid-19 Pfizer BioNTech Bivalent for this patinets booster dose.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea
Clinical narrative: SOB
Age: 69.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: The patient was given an expired COVID shot. The vial was only good for 12 hours upon puncture. The vial was opened on 09/19/2022 at 16:50pm so it was expired when it was administered at 8:33am on 09/20/2022. The error was discovered right away and notified the patient and the provider. The patient was given another COVID Bivalent shot.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: No adverse reaction- incorrect vaccine given dose should have Been Covid-19 Pfizer BioNTech Bivalent for this patinets booster dose.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered, Incorrect product formulation administered, No adverse event
Clinical narrative: No adverse reaction- incorrect vaccine given dose should have Been Covid-19 Pfizer BioNTech Bivalent for this patinets booster dose.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, Incorrect product formulation administered, No adverse event
Clinical narrative: No adverse reaction- incorrect vaccine given dose should have Been Covid-19 Pfizer BioNTech Bivalent for this patinets booster dose.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Atrial fibrillation, Atrial flutter, COVID-19, Cardiac failure congestive, Death
Clinical narrative: Patient tested positive for Covid 8-11-22. He was seen in ER 8-10-22 and admitted 8-11-22. All Covid medical therapies, he did not want intubation and was given non invasive ventilation. Placed on comfort measures. Passed away in the hospital on 8-31-22. Death Note includes Covid 19; respiratory failure; CAP; elevated troponin I level, new onset AFib, CHF, bright red blood per rectum, transient AFib/flutter.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Mechanical ventilation, Pneumonia, Rectal haemorrhage, Respiratory failure, SARS-CoV-2 test positive
Clinical narrative: Patient tested positive for Covid 8-11-22. He was seen in ER 8-10-22 and admitted 8-11-22. All Covid medical therapies, he did not want intubation and was given non invasive ventilation. Placed on comfort measures. Passed away in the hospital on 8-31-22. Death Note includes Covid 19; respiratory failure; CAP; elevated troponin I level, new onset AFib, CHF, bright red blood per rectum, transient AFib/flutter.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Troponin I increased
Clinical narrative: Patient tested positive for Covid 8-11-22. He was seen in ER 8-10-22 and admitted 8-11-22. All Covid medical therapies, he did not want intubation and was given non invasive ventilation. Placed on comfort measures. Passed away in the hospital on 8-31-22. Death Note includes Covid 19; respiratory failure; CAP; elevated troponin I level, new onset AFib, CHF, bright red blood per rectum, transient AFib/flutter.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Hospitalized with covid; fully vaccinated
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Dyspnoea, Fatigue, Pyrexia, Respiratory tract congestion
Clinical narrative: fatigue, fever, congestion, chest tightness, SOB
Age: 39.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Animal scratch, COVID-19, Cellulitis, Cough, SARS-CoV-2 test positive
Clinical narrative: Pt admitted for cellulitis of the right forearm post cat scratch. Pt stated that he tested positive on home test for COVID and was positive here. Pt had no fever, but just a cough.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Cough, Fatigue
Clinical narrative: The symptoms started August 30th at night with a mild cough, my husband was sicker than me earlier in the day. As the night went on it felt like someone took a blanket and dropped it over my head. I had fatigue, aches and pains on my body, I didn't feel good at all. I felt like I was getting a fever but my temp was 99 and never went over that. I also had a bad runny nose. The cough got worse and I had a lot of fluid in my chest that was productive for a week. I now have a dry cough. I lost my taste and smell for food which made me not want to eat. I took extra strength TYLENOL 2-3 times a day because my body hurt. This stayed for a week. Then started feeling better with a dry cough but still very tired. We got PAXLOVID and took it for 5 days and didn't have any reaction to it but I was still sick.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Malaise, Pain, Respiratory tract congestion, Rhinorrhoea
Clinical narrative: The symptoms started August 30th at night with a mild cough, my husband was sicker than me earlier in the day. As the night went on it felt like someone took a blanket and dropped it over my head. I had fatigue, aches and pains on my body, I didn't feel good at all. I felt like I was getting a fever but my temp was 99 and never went over that. I also had a bad runny nose. The cough got worse and I had a lot of fluid in my chest that was productive for a week. I now have a dry cough. I lost my taste and smell for food which made me not want to eat. I took extra strength TYLENOL 2-3 times a day because my body hurt. This stayed for a week. Then started feeling better with a dry cough but still very tired. We got PAXLOVID and took it for 5 days and didn't have any reaction to it but I was still sick.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: The symptoms started August 30th at night with a mild cough, my husband was sicker than me earlier in the day. As the night went on it felt like someone took a blanket and dropped it over my head. I had fatigue, aches and pains on my body, I didn't feel good at all. I felt like I was getting a fever but my temp was 99 and never went over that. I also had a bad runny nose. The cough got worse and I had a lot of fluid in my chest that was productive for a week. I now have a dry cough. I lost my taste and smell for food which made me not want to eat. I took extra strength TYLENOL 2-3 times a day because my body hurt. This stayed for a week. Then started feeling better with a dry cough but still very tired. We got PAXLOVID and took it for 5 days and didn't have any reaction to it but I was still sick.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Dyspnoea, Respiratory tract congestion, Wheezing
Clinical narrative: congestion, cough, SOB, wheezing
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Affective disorder, Disorientation
Clinical narrative: mood problem, disorientation
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Hospitalized with Covid; fully vaccinated with booster.